
The once-daily device, bioequivalent to the existing prefilled syringe, gives adults with AChR antibody-positive generalized MG a second self-injection option.
Top stories of the week on Specialty Pharmacy Times from June 22-26.
[<a href="//storify.com/pharmacytimes/cancer-drugs-in-dogs-highlight-specialty-pharmacy-" target="_blank">View the story "Cancer Drugs in Dogs Highlight Specialty Pharmacy Week in Review" on Storify</a>]




